These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6436959)

  • 1. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
    Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
    Rondier J; Huchet B; Cayla J
    Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):49-54. PubMed ID: 6420876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudosarcomatous osteolysis of the femur in a patient with Paget's bone disease treated with long-term etidronate disodium: apropos of a new case].
    Marin F; Billey T; Lassoued S
    Rev Med Interne; 1996; 17(10):856-8. PubMed ID: 8976984
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteolytic Paget's disease of bone under unduly etidronate therapy.
    Wendling D; Guidet M
    Clin Rheumatol; 1988 Dec; 7(4):543-5. PubMed ID: 3149926
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep; 20(18):78-9. PubMed ID: 99647
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
    Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudotumoral osteolysis caused by diphosphonates].
    Fedou P; Codine P; Simon L
    Rev Rhum Mal Osteoartic; 1986 Apr; 53(4):293-4. PubMed ID: 3090678
    [No Abstract]   [Full Text] [Related]  

  • 10. Etidronate disodium in the treatment of Paget's disease of bone.
    Krane SM
    Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
    Ravault A; Meunier PJ
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
    Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
    Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 14. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 15. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
    Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
    Reginster JY; Gritten C; Diverse P; Hauwaert PC; Crielaard JM; Halleux R; Franchimont P
    Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):145-50. PubMed ID: 3923603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
    Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
    Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new case of pseudosarcomatous osteolysis in a patient with Paget's disease treated with disodium etidronate].
    Chapuis L; Oudry B; Jacomy LP; Lancien G; Morel B
    Presse Med; 1990 Jan 6-13; 19(1):34. PubMed ID: 2153954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.